Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial

Journal:

Nature Communications

Published:

2025-08-26

DOI:

10.1038/s41467-025-62678-x

Affiliations:

36

Authors:

32

Go to article

Institutions	Authors	Share
Institute of Cancer Research (ICO), France	2.000000	0.06
Cancer and Brain Genomics (CBG), France	2.000000	0.06
Curie Institute, France	1.500000	0.05
Paris Cité University, France	1.500000	0.05
Centre François Baclesse, France	1.000000	0.03
Institute Gustave-Roussy (IGR), France	1.000000	0.03
ARCAGY-GINECO, France	1.000000	0.03
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France	1.000000	0.03
L'Hôpital Jean Minjoz, France	1.000000	0.03
Bergonié Cancer Institute, France	1.000000	0.03
Centre Georges-François Leclerc (CGFL), France	1.000000	0.03
CHU Saint Etienne, France	1.000000	0.03
Centre Azuréen de Cancérologie (ACC), France	1.000000	0.03
Groupe Hospitalier Diaconesses Croix Saint-Simon, France	1.000000	0.03
Lorraine Institute of Oncology (ICL), France	1.000000	0.03
Hôpital Saint Joseph - Marseille, France	1.000000	0.03
Centre Antoine-Lacassagne (CAL), France	1.000000	0.03
Centre Hospitalier Régional d'Orléans (CHR d’Orléans), France	1.000000	0.03
Institut du Cancer de Montpellier (ICM), France	1.000000	0.03
Centre Armoricain De Radiothérapie, D'imagerie Médicale Et D'oncologie (CARIO), France	1.000000	0.03
Centre Hospitalier Intercommunal de Créteil (CHIC), France	1.000000	0.03
Centre Oscar Lambret, France	1.000000	0.03
Groupe Hospitalier Mutualiste de Grenoble, France	1.000000	0.03
Institut Sainte Catherine, France	1.000000	0.03
Centre Jean Bernard, France	1.000000	0.03
Cochin Hospital, France	1.000000	0.03
Lyon University Hospital (HCL), France	1.000000	0.03
Centre Léon Bérard (CLB), France	0.500000	0.02
University of Lyon, France	0.500000	0.02
Georges Pompidou European Hospital (HEGP), France	0.500000	0.02
Université PSL, France	0.500000	0.02

Interested in Oncology and Carcinogenesis?